Effects of REM sleep awakenings and related wakening paradigms on the ultradian sleep cycle and the symptoms in depression.
Level 2 - randomized trial
Controlled clinical trial comparing two intervention paradigms
PubMed 12127597 · doi:10.1016/s0022-3956(02)00022-5
What was done
Researchers developed an artificial neural network software system to detect REM sleep in real time and trigger an alarm, reducing REM sleep by approximately 50%. They compared this REM awakening protocol (n = 14) against a modified non-REM awakening protocol (n = 13) across 10 consecutive nights in depressed patients. All participants concurrently received moderate dosages of trimipramine.
What was found
Both groups showed substantial reductions in average Hamilton depression rating scores (33% and 41% reductions from baseline), with no statistically significant difference between the two paradigms. REM sleep awakenings shortened the ultradian sleep cycle duration, whereas the non-REM intervention lengthened it.
Why it matters
The findings challenge earlier classic studies suggesting selective REM deprivation has superior antidepressant effects compared to control awakenings, indicating that general perturbation of the sleep cycle or medication effects may drive symptom reduction.
Limits
The sample size was small (total n = 27). All patients received concurrent trimipramine, confounding whether symptom improvements were driven by medication, sleep disruption, or an interaction. The abstract does not state whether allocation was randomized or if raters were blinded.
Cited by
- contradicts Rapid eye movement (REM) sleep has been used as a clinical treatment for depression.